We are live on ! Find out more
DNA.WS

Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS

Delisted

DNA.WS was delisted on the 3rd of September, 2024.

Back to rankings

3 hedge funds and large institutions have $2 invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less capital invested

Capital invested by funds: $3.66K → $2 (-$3.66K)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AS
Altshuler Shaham
Israel
-$3.66K
Name Holding Trade Value Shares
Change 		Change in
Stake
HIA
1
Harbor Investment Advisory
Maryland
$1 – – –
NC
2
NewSquare Capital
Pennsylvania
$1 – – –
AS
3
Altshuler Shaham
Israel
– -$3.66K -576,345 Closed

DNA.WS Hedge Fund Activity: Q1 2025 in Review

3 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) for Q1 2025, worth a combined $2 — down 100% from $3.66K a quarter earlier.

Fund positioning in DNA.WS was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Altshuler Shaham, exiting entirely with an estimated $3.66K sold.

  • 3 institutional investors held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $2 of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share stock for Q1 2025, down 100% quarter-over-quarter.
  • 1 fund opened new Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share positions in Q1 2025 and 1 closed out, a net change of 0 holders.
  • The largest Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share seller in Q1 2025 was Altshuler Shaham, an estimated $3.66K sold.

Based on aggregated 13F filings for Q1 2025.